How to use the speech recognition tool?
NCT00481546
LCA
Phase I Trial of Gene Vector to Patients with Retinal Disease due to
RPE65 mutations
Type: Interventional
Status of the trial: Active, Not recruiting
Orphan Drug Recognition: NA
Inclusion
- Opening Date: 2007-07-01
- Closing Date: 2026-06-01
Criteria
Children: Yes
Adults: Yes
Funder Type: other
HCP: Principal investigators
HCP: Other investigators
Within ERN-EYE members
Workgroups
Retinal Rare Eye Diseases (WG1)